Newbridge Financial Services Group’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-70	Closed	-$1.46K	–	1121
2023 Q3	$1.46K	Hold	70	–	–	﹤0.01%	1119
2023 Q2	$1.68K	Hold	70	–	–	﹤0.01%	1157
2023 Q1	$1.32K	Hold	70	–	–	﹤0.01%	1251
2022 Q4	$1.11K	Hold	70	–	–	﹤0.01%	1289
2022 Q3	$1K	Hold	70	–	–	﹤0.01%	1263
2022 Q2	$1K	Hold	70	–	–	﹤0.01%	1242
2022 Q1	$2K	Hold	70	–	–	﹤0.01%	1260
2021 Q4	$2K	Sell	70 -150	-68%	-$3.02K	﹤0.01%	1208
2021 Q3	$4K	Sell	220 -150	-41%	-$2.89K	﹤0.01%	1037
2021 Q2	$9K	Hold	370	–	–	0.01%	999
2021 Q1	$10K	Buy	370 +70	+23%	+$3.08K	0.01%	888
2020 Q4	$16K	Hold	300	–	–	0.01%	592
2020 Q3	$12K	Buy	+300	New	+$13K	0.01%	620